Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study

Acta Neuropathologica

Volumn 105, Issue 5, 2003, Pages 415-419

  Jellinger, Kurt A ^a  

^a INSTITUTE OF CLINICAL NEUROBIOLOGY   (Austria)

Author keywords

Lewy body disease; Parkinson's disease; Postmortem study; Stroke incidence

Indexed keywords

ADULT; AGED; ARTICLE; AUTOPSY; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CONTROLLED STUDY; DEATH; DIFFUSE LEWY BODY DISEASE; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; STROKE; VASCULAR AMYLOIDOSIS; VASCULAR DISEASE; WHITE MATTER; BRAIN; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; RETROSPECTIVE STUDY;

AMYLOID BETA PROTEIN; NERVE PROTEIN; SYNUCLEIN; TAU PROTEIN;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PROTEIN; AUTOPSY; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NERVE TISSUE PROTEINS; PARKINSON DISEASE; RETROSPECTIVE STUDIES; SYNUCLEINS; TAU PROTEINS;

EID: 0038798102     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00401-003-0676-3     Document Type: Article

References (38)

1. American Psychiatric Association (1999) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
2. Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F (1996) Correlations between mental state and quantitative neuropathology in the Vienna Longitudinal Study on Dementia. Eur Arch Psychiatry Clin Neurosci 246:137-146
3. Ben-Shlomo Y, Marmot MG (1995) Survival and cause of death in a cohort of patients with parkinsonism: possible clues to aetiology? J Neurol Neurosurg Psychiatry 58:293-299
4. Bodenmann P, Ghika J, Van Melle G, Bogousslavsky J (2001) Comorbidité neurologique du parkinsonism. Rev Neurol 157: 45-54
5. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82:239-259
6. Calne DB, Snow BJ, Lee C (1992) Criteria for diagnosing Parkinson's disease. Ann Neurol 32 Suppl:S125-S127
7. Crystal H, Dickson D (2002) Cerebral infarcts in patients with autopsy proven Alzheimer's disease. Neurobiol Aging 23 (Suppl 1):207
8. Esiri MM, Nagy Z, Smith MZ, Barnetson L, Smith AD (1999) Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet 346:919-920
9. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-Mental" state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
10. Gorell JM, Johnson CC, Rybicki BA (1994) Parkinson's disease and its comorbid disorders: an analysis of Michigan mortality data, 1970 to 1990. Neurology 44:1865-1868
11. Hansen LA (1997) The Lewy body variant of Alzheimer disease. J Neural Transm Suppl 51:83-93
12. Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427-442
13. Hughes AJ, Daniel SE, Blankson S, Lees AJ (1993) A clinicopathologic study of 100 cases of Parkinson's disease. Arch Neurol 50:140-148
14. Hughes AJ, Daniel SE, Lees AJ (2001) Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology 57:1497-1499
15. Hyman BT (1998) New neuropathological criteria for Alzheimer disease. Arch Neurol 55:1174-1176
16. Iwasaki S, Narabayashi Y, Hamaguchi K, Iwasaki A, Takakusagi M (1990) Cause of death among patients with Parkinson's disease: a rare mortality due to cerebral haemorrhage. J Neurol 237:77-79
17. Jellinger KA (2001) Small concomitant cerebrovascular lesions are not important for cognitive decline in severe Alzheimer disease (letter). Arch Neurol 58:520-521
18. Jellinger KA (2001) The pathology of Parkinson's disease. Adv Neurol 86:55-72
19. Jellinger KA (2002) Vascular parkinsonism - neuropathological findings. Acta Neurol Scand 105:414-415
20. Jellinger KA (2002) Vascular ischemic dementia: an update. J Neural Transm (Suppl.62):1-23
21. Jellinger KA, Attems J (2003) Prevalence of cerebrovascular lesions in Alzheimer disease. A postmortem study. Acta Neuropathol 105:14-17
22. Jellinger KA, Seppi K, Wenning GK, Poewe W (2002) Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease. J Neural Transm 109:329-339
23. Kessler II (1972) Epidemiologic studies of Parkinson's disease. 3. A community-based survey. Am J Epidemiol 96:242-254
24. Khachaturian ZS (1985) Diagnosis of Alzheimer's disease. Arch Neurol 42:1097-1105
25. Korten A, Lodder J, Vreeling F, Boreas A, Raak L van, Kessels F (2001) Stroke and idiopathic Parkinson's disease: does a shortage of dopamine offer protection against stroke? Mov Disord 16:119-123
26. Lee JH, Olichney JM, Hansen LA, Hofstetter CR, Thal LJ (2000) Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol 57:1474-1479
27. Levine RL, Jones JC, Bee N (1992) Stroke and Parkinson's disease. Stroke 23:839-842
28. Mastaglia FL, Johnsen RD, Kakulas BA (2002) Prevalence of stroke in Parkinson's disease: A postmortem study. Mov Disord 17:772-774
29. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, Salmon DP, Lowe J, Mirra SS, Byrne EJ, Lennox G, Quinn NP, Edwardson JA, Ince PG, Bergeron C, Burns A, Miller BL, Lovestone S, Collerton D, Jansen EN, Ballard C, Vos RA de, Wilcock GK, Jellinger JA, Perry RH (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB). Report of the consortium on DLB international workshop. Neurology 47:1113-1124
30. McKeith IG, Perry EK, Perry RH (1999) Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies. Neurology 53:902-905
31. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, Vogel FS, Hughes JP, Belle G van, Berg L (1991) The consortium to establish a registry for Alzheimer's disease (CERAD). Part II: Standardization of the Neuropathologic Assessment of Alzheimer's disease. Neurology 41:479-486
32. Rajput DR, Rozdislky B, Rajput AH (1992) Accuracy of the clinical diagnosis in parkinsonism. A prospective study. Can J Neurol 55:181-184
33. Robinson C (2002) The role of anatomical pathology in understanding human movement disorders. Parkinsonism Relat Disord 8:439
34. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesberry WR (1997) Brain infarction and the clinical expression of Alzheimer disease - the NUN study. JAMA 277: 813-817
35. Struck LK, Rodnitzky RL, Dobson JK (1990) Stroke and its modification in Parkinson's disease. Stroke 21:1395-1399
36. Vinters HV, Ellis WG, Zarow C, Zaias BW, Jagust WJ, Mack WJ, Chui HC (2000) Neuropathologic substrates of ischemic vascular dementia. J Neuropathol Exp Neurol 59:931-945
37. Wrocklage C, Bernatik J, Stefan H, Jellinger KA, Paulus W (1999) Apolipoprotein E genotype in epilepsy and schizophrenia patients with cognitive deficits. Acta Neuropathol 98:517-563
38. Zekry D, Duyckaerts C, Moulias R, Belmin J, Geoffre C, Herrmann F, Hauw JJ (2002) Degeneration and vascular lesions of the brain have synergistic effects in the dementia of the elderly. Acta Neuropathol 103:481-487